Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility
Barbora Dobiasova, Michal Mego 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovak RepublicCorrespondence: Michal Mego 2 nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Klenova 1, Bratisl...
Enregistré dans:
Auteurs principaux: | Dobiasova B, Mego M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/02dcb47d941a4a6a9f0c1b0d187f4a58 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
par: Kexin Xu, et autres
Publié: (2021) -
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
par: Fleisher B, et autres
Publié: (2016) -
Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
par: Marta Truffi, et autres
Publié: (2021) -
Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
par: Jesse Lopes da Silva, et autres
Publié: (2021) -
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors
par: Koleck TA, et autres
Publié: (2017)